{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:15:20Z","timestamp":1761513320905},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2013,7,15]],"date-time":"2013-07-15T00:00:00Z","timestamp":1373846400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/"},{"start":{"date-parts":[[2013,7,15]],"date-time":"2013-07-15T00:00:00Z","timestamp":1373846400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/srep02183","type":"journal-article","created":{"date-parts":[[2013,7,15]],"date-time":"2013-07-15T09:02:45Z","timestamp":1373878965000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Initial Pulmonary Respiration Causes Massive Diaphragm Damage and Hyper-CKemia in Duchenne Muscular Dystrophy Dog"],"prefix":"10.1038","volume":"3","author":[{"given":"Akinori","family":"Nakamura","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masanori","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mutsuki","family":"Kuraoka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katsutoshi","family":"Yuasa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoko","family":"Yugeta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Okada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shin'ichi","family":"Takeda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,7,15]]},"reference":[{"key":"BFsrep02183_CR1","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1096\/fj.12-208967","volume":"27","author":"J Sarkis","year":"2012","unstructured":"Sarkis, J. et al. Resisting sarcolemmal rupture: dystrophin repeats increase membrane-actin stiffness. FASEB 27, 359\u2013369 (2012).","journal-title":"FASEB"},{"key":"BFsrep02183_CR2","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.ajpath.2010.11.027","volume":"178","author":"LH J\u00f8rgensen","year":"2011","unstructured":"J\u00f8rgensen, L. H. et al. Long-term blocking of calcium channels in mdx mice results in differential effects on heart and skeletal muscle. Am J Pathol 178, 273\u201383 (2011).","journal-title":"Am J Pathol"},{"key":"BFsrep02183_CR3","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/BF00687043","volume":"69","author":"Y Tanabe","year":"1986","unstructured":"Tanabe, Y., Esaki, K. & Nomura, T. Skeletal muscle pathology in X-chromosome-linked muscular dystrophy (mdx) mouse. Acta Neuropathol (Berl.) 69, 91\u201395 (1986).","journal-title":"Acta Neuropathol (Berl.)"},{"key":"BFsrep02183_CR4","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/0022-510X(88)90206-7","volume":"88","author":"BA Valentine","year":"1988","unstructured":"Valentine, B. A., Cooper, B. J., de lahunta, A., O'Quinn, R. & Blue, J. T. An animal model of Duchenne muscular dystrophy: clinical studies. J Neurol Sci 88, 69\u201381 (1988).","journal-title":"J Neurol Sci"},{"key":"BFsrep02183_CR5","first-page":"145","volume":"24","author":"Y Shimatsu","year":"2005","unstructured":"Shimatsu, Y. et al. Major clinical and histopathological characteristics of canine X-linked muscular dystrophy in Japan, CXMDJ. Acta Myologica 24, 145\u2013154 (2005).","journal-title":"Acta Myologica"},{"key":"BFsrep02183_CR6","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1007\/BF01790793","volume":"44","author":"H Heyck","year":"1966","unstructured":"Heyck, H., Laudahn, G. & Carsten, P. M. Enzymatktivit\u00e4tsbestimmungen bei dystrophia musculorum progressia. IV. Mitterilung. Die serumenzymkinetik im pr\u00e4klinischen stadium des typus Duchenne w\u00e4hrend der ersten 2 lebensjahre. Klin Wochnschr 44, 695\u2013700 (1966).","journal-title":"Klin Wochnschr"},{"key":"BFsrep02183_CR7","first-page":"271","volume":"50","author":"J Demos","year":"1971","unstructured":"Demos, J. Early diagnosis and treatment of rapidly developing Duchenne de Boulogne type myopathy (type DDBI). Am J Phys Med 50, 271\u2013284 (1971).","journal-title":"Am J Phys Med"},{"key":"BFsrep02183_CR8","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1542\/peds.55.1.30","volume":"55","author":"H Zellweger","year":"1975","unstructured":"Zellweger, H. & Antonik, A. Newborn screening for Duchenne muscular dystrophy. Pediatrics 55, 30\u201334 (1975).","journal-title":"Pediatrics"},{"key":"BFsrep02183_CR9","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1542\/peds.38.6.1039","volume":"38","author":"N Rudolph","year":"1966","unstructured":"Rudolph, N. & Gross, R. T. Creatine phsophokinase activity in serum of newborn infants as indicator of fetal trauma during birth. Pediatrics 38, 1039\u20131046 (1966).","journal-title":"Pediatrics"},{"key":"BFsrep02183_CR10","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1136\/adc.54.5.362","volume":"54","author":"LM Drumond","year":"1979","unstructured":"Drumond, L. M. Creatine phosphokinase levels in the newborn and their use in screening for Duchenne muscular dystrophy. Arch Dis Child 54, 362\u2013366 (1979).","journal-title":"Arch Dis Child"},{"key":"BFsrep02183_CR11","doi-asserted-by":"crossref","first-page":"28261","DOI":"10.1074\/jbc.M103608200","volume":"276","author":"R Agnihotri","year":"2001","unstructured":"Agnihotri, R. et al. Osteopontin, a novel substrate for matrix metalloproteinase-3 (stromelysin-1) and matrix metalloproteinase-7 (matrilysin). J Biol Chem 276, 28261\u201328267 (2001).","journal-title":"J Biol Chem"},{"key":"BFsrep02183_CR12","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.2353\/ajpath.2010.091081","volume":"177","author":"A Goncalves DaSilva","year":"2010","unstructured":"Goncalves DaSilva, A., Liaw, L. & Yong, V. W. Cleavage of osteopontin by matrix metalloproteinase-12 modulates experimental autoimmune encephalomyelitis disease in C57BL\/6 mice. Am J Pathol 177, 1448\u20131458 (2010).","journal-title":"Am J Pathol"},{"key":"BFsrep02183_CR13","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s004010050965","volume":"97","author":"M Lanfossi","year":"1999","unstructured":"Lanfossi, M. et al. Development of muscle pathology in canine X-linked muscular dystrophy. I. Delayed postnatal maturation of affected and normal muscle as revealed by myosin isoform analysis and utrophin expression. Acta Neuropathol 97, 127\u2013138 (1999).","journal-title":"Acta Neuropathol"},{"key":"BFsrep02183_CR14","first-page":"251","volume":"4","author":"JE Malney","year":"1980","unstructured":"Malney, J. E., Alcom, D., Bowes, G. & Wilkinson, M. Development of the future respiratory system before birthe. Semin Perinatol 4, 251\u2013260 (1980).","journal-title":"Semin Perinatol"},{"key":"BFsrep02183_CR15","doi-asserted-by":"crossref","first-page":"2302","DOI":"10.1161\/ATVBAHA.107.144824","volume":"27","author":"M Scatena","year":"2007","unstructured":"Scatena, M., Liaw, L. & Giachelli, C. M. Osteopontin: a multifunctional molecule regulating chronic inflammation and vascular disease. Arterioscler Thromb Vasc Biol 27, 2302\u20132309 (2007).","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"BFsrep02183_CR16","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1111\/j.1365-2559.2011.04051.x","volume":"59","author":"S Zanotti","year":"2011","unstructured":"Zanotti, S. et al. Osteopontin is highly expressed in severely dystrophic muscle and seems to play a role in muscle regeneration and fibrosis. Histopathology 59, 1215\u20131228 (2011).","journal-title":"Histopathology"},{"key":"BFsrep02183_CR17","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1152\/japplphysiol.00080.2007","volume":"103","author":"BK Pedersen","year":"2007","unstructured":"Pedersen, B. K., \u00c5kerstr\u00f6m, T. C., Nielsen, A. R. & Fischer, C. P. Role of myokines in exercise and metabolism. J Appl Physiol 103, 1093\u20131098 (2007).","journal-title":"J Appl Physiol"},{"key":"BFsrep02183_CR18","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1002\/mus.23317","volume":"46","author":"JA Mathers","year":"2012","unstructured":"Mathers, J. A., Farnfield, M. M., Garnham, A. P., Caldow, M. K. & Cameron-Smith, D. Early inflammatory and myogenic responses to resistance exercise in the elderly. Muscle Nerve 46, 407\u2013412 (2012)","journal-title":"Muscle Nerve"},{"key":"BFsrep02183_CR19","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1002\/art.24625","volume":"60","author":"W Zheng","year":"2009","unstructured":"Zheng, W. et al. Role of osteopontin in induction of monocyte chemoattractant proein 1 and macrophage inflammatory protein 1beta through the NF-kappaB and MAPK pathways inrheumatoid arthritis. Arthritis Rheum 60, 1957\u20131965 (2009)","journal-title":"Arthritis Rheum"},{"key":"BFsrep02183_CR20","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0002-9440(10)63644-9","volume":"163","author":"H Hirata","year":"2003","unstructured":"Hirata, H. et al. Expression profiling of cytokines and related genes in regenerating skeletal muscle after cardiotoxin injection: a role for osteopontin. Am J Pathol 163, 203\u2013205 (2003).","journal-title":"Am J Pathol"},{"key":"BFsrep02183_CR21","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1172\/JCI37662","volume":"119","author":"SA Vetrone","year":"2009","unstructured":"Vetrone, S. A. et al. Osteopontin promotes fibrosis in dystrophic mouse muscle by modulating immune cell subsets and intramuscular TGF-beta. J Clin Invest 119, 1583\u20131594 (2009).","journal-title":"J Clin Invest"},{"key":"BFsrep02183_CR22","doi-asserted-by":"crossref","first-page":"2723","DOI":"10.4049\/jimmunol.1101342","volume":"187","author":"S Dahiya","year":"2011","unstructured":"Dahiya, S. et al. Osteopontin-stimulated expression of matrix metalloproteinase-9 causes cardiomyopathy in the mdx model of Duchenne musucular dystrophy. J Immnol 187, 2723\u20132731 (2011).","journal-title":"J Immnol"},{"key":"BFsrep02183_CR23","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/1471-2474-8-54","volume":"8","author":"K Fukushima","year":"2007","unstructured":"Fukushima, K. et al. Activation and localization of matrix metalloproteinase-2 and -9 in the skeletal muscle of muscular dystrophy dog (CXMDJ). BMC Musculoskelet Disord 8, 54 (2007).","journal-title":"BMC Musculoskelet Disord"},{"key":"BFsrep02183_CR24","doi-asserted-by":"crossref","first-page":"4345","DOI":"10.1093\/hmg\/ddr362","volume":"20","author":"S Dahiya","year":"2011","unstructured":"Dahiya, S. et al. Elevated levels of active matrix metalloproteinase-p cause hypertrophy in skeletal muscle of normal and dystrophin-deficient mdx mice. Hum Mol Genet 20, 4345\u20134359 (2011).","journal-title":"Hum Mol Genet"},{"key":"BFsrep02183_CR25","doi-asserted-by":"crossref","first-page":"159","DOI":"10.3109\/19390211.2010.482041","volume":"7","author":"MM Qureshi","year":"2010","unstructured":"Qureshi, M. M. et al. The dietary supplement protandium decreases plasma osteopontin and improves markers of oxidative stress in muscular dystrophy mdx mice. J Diet Suppl 7, 159\u2013178 (2010).","journal-title":"J Diet Suppl"},{"key":"BFsrep02183_CR26","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.2353\/ajpath.2010.091081","volume":"177","author":"AG DaSilva","year":"2010","unstructured":"DaSilva, A. G., Liaw, L. & Yong, V. W. Cleavage of osteopontin by matrix metalloproteinase-12 modulates experimental autoimmune encephalomyeltitis disease in C57BL\/6 mice. Am J Pathol 177, 1448\u20131458 (2010).","journal-title":"Am J Pathol"},{"key":"BFsrep02183_CR27","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/S0962-8924(02)02412-1","volume":"12","author":"MJ Wishart","year":"2002","unstructured":"Wishart, M. J. & Dixon, J. E. PTEN and myotubularin phosphatases: from 3-phosphoinositide dephosphorylation to disease. TRENDS in Cell Biol 12, 579\u2013585 (2002).","journal-title":"TRENDS in Cell Biol"},{"key":"BFsrep02183_CR28","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1002\/(SICI)1097-4598(199610)19:10<1291::AID-MUS6>3.0.CO;2-9","volume":"19","author":"JB Kurek","year":"1996","unstructured":"Kurek, J. B., Nouri, S., Kannourakis, G., Murphy, M. & Austin, L. Leukemia inhibitory factor and interleukin-6 are produced by diseased and regenerating skeletal muscle. Muscle Nerve 19, 1291\u20131301 (1996).","journal-title":"Muscle Nerve"},{"key":"BFsrep02183_CR29","first-page":"505","volume":"355","author":"A Schaefer","year":"1988","unstructured":"Schaefer, A., Magocsi, M., Fandrich, A. & Marquardt, H. Stimulation of the Ca2+-mediated egr-1 and c-fos expression in murine erythroleukaemia cells by cyclosporin A. . Biochem J 355, 505\u2013511 (1988).","journal-title":"Biochem J"},{"key":"BFsrep02183_CR30","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1091\/mbc.10.4.1247","volume":"10","author":"KP Grembowicz","year":"1999","unstructured":"Grembowicz, K. P., Sprague, D. & McNeil, P. L. Temporary disruption of the plasma membrane is required for c-fos expression in response to mechanical stress. Mol Biol Cell 10, 1247\u20131257 (1999).","journal-title":"Mol Biol Cell"},{"key":"BFsrep02183_CR31","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1006\/cyto.2001.0856","volume":"14","author":"JJ Schuringa","year":"2001","unstructured":"Schuringa, J. J., Timmer, H., Luttickhuizen, D., Vellenga, E. & Kruijer, W. c-Jun and c-Fos cooperate with STAT3 in IL-6-induced transactivation of the IL-6 respone element (IRE). Cytokine 14, 78\u201387 (2001).","journal-title":"Cytokine"},{"key":"BFsrep02183_CR32","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1016\/j.molimm.2010.03.003","volume":"47","author":"EM Cullen","year":"2010","unstructured":"Cullen, E. M., Brazil, J. C. & O'Connor, C. M. Mature human neutrophils constitutively express the transcription factor EGR-1. Mol Immunol 47, 1701\u20131709 (2010).","journal-title":"Mol Immunol"},{"key":"BFsrep02183_CR33","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1096\/fj.01-0876rev","volume":"16","author":"MA Febbraio","year":"2002","unstructured":"Febbraio, M. A. & Pedersen, B. K. Muscle-derived interleukin-6: mechanisms for activation and possible biological roles. FASEB J 16, 1335\u20131347 (2002).","journal-title":"FASEB J"},{"key":"BFsrep02183_CR34","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1152\/japplphysiol.90584.2008","volume":"106","author":"JM Peterson","year":"2009","unstructured":"Peterson, J. M. & Pizza, F. X. Cytokines derived from cultured skeletal muscle cells after mechanical strain promote neutrophil chemotaxis in vitro. J Appl Physiol 106, 130\u2013137 (2009).","journal-title":"J Appl Physiol"},{"key":"BFsrep02183_CR35","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1007\/s00109-011-0784-9","volume":"89","author":"B McDonald","year":"2011","unstructured":"McDonald, B. & Kubes, P. Cellular and molecular choreography of neutrophil recruitment to site of sterile inflammation. J Mol Med 89, 1079\u20131088 (2011).","journal-title":"J Mol Med"},{"key":"BFsrep02183_CR36","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.nmd.2006.06.011","volume":"16","author":"S Hodgetts","year":"2006","unstructured":"Hodgetts, S., Radley, H., Davies, M. & Grounds, M. D. Reduced necrosis of dystrophic muscle by depletion of host neutrophils, or blocking TNFalpha function with Etanercept in mdx mice. Neuromuscl Disord 16, 591\u2013602 (2006).","journal-title":"Neuromuscl Disord"},{"key":"BFsrep02183_CR37","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s001090000094","volume":"78","author":"DW Gilroy","year":"2000","unstructured":"Gilroy, D. W. & Volville-Nash, P. R. New insights into the role of COX-2 in inflammation. J Mol Med 78, 121\u2013129 (2000).","journal-title":"J Mol Med"},{"key":"BFsrep02183_CR38","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.expneurol.2009.09.015","volume":"220","author":"S Messina","year":"2009","unstructured":"Messina, S. et al. Flavocoxid counteracts muscle necrosis and improves functional properties in mdx mice: a comparison study with methylprednisolone. Exp Neurol 220, 349\u2013358 (2009).","journal-title":"Exp Neurol"},{"key":"BFsrep02183_CR39","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1002\/mus.23432","volume":"46","author":"F Serra","year":"2012","unstructured":"Serra, F. et al. Inflammation in muscular dystrophy and the beneficial effects of non-steroidal anti-inflammatory drugs. Muscle Nerve 46, 773\u2013784 (2012).","journal-title":"Muscle Nerve"},{"key":"BFsrep02183_CR40","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1007\/BF00690539","volume":"75","author":"M Uchino","year":"1988","unstructured":"Uchino, M., Araki, S. & Miike, T. Correlative study of the incidence of opaque, necrotic and regenerative fibers in Duchenne dystrophy. Acta Neuropathol 75, 308\u2013312 (1988).","journal-title":"Acta Neuropathol"},{"key":"BFsrep02183_CR41","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1093\/hmg\/ddg065","volume":"12","author":"S Noguchi","year":"2003","unstructured":"Noguchi, S. et al. cDNA microarray analysis of individual Duchenne muscular dystrophy patients. Hum Mol Genet 12, 595\u2013600 (2003).","journal-title":"Hum Mol Genet"},{"key":"BFsrep02183_CR42","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S1474-4422(09)70271-6","volume":"9","author":"K Bushby","year":"2010","unstructured":"Bushby, K. et al. Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis and pharmacological and psychosocial management. Lancet Neurol 9, 77\u201393 (2010).","journal-title":"Lancet Neurol"},{"key":"BFsrep02183_CR43","doi-asserted-by":"crossref","first-page":"147","DOI":"10.2500\/108854199778553082","volume":"20","author":"M Frieri","year":"1999","unstructured":"Frieri, M. Corticosteriod effects on cytokines and chemokines. Allergy Asthma Proc 20, 147\u2013159 (1999).","journal-title":"Allergy Asthma Proc"},{"key":"BFsrep02183_CR44","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.ejphar.2007.12.033","volume":"583","author":"R Malcher-Lopes","year":"2008","unstructured":"Malcher-Lopes, R., Franco, A. & Tasker, J. G. Glucocorticoids shift arachidonic acid metabolism toward endocannabinoid synthesis: a non-genomic anti-inflammatory switch. Eur J Pharm 583, 322\u2013339 (2008).","journal-title":"Eur J Pharm"},{"key":"BFsrep02183_CR45","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1002\/mus.21384","volume":"40","author":"M Kobayashi","year":"2009","unstructured":"Kobayashi, M. et al. Evaluation of dystrophic dog pathology by fat-suppressed T2-weighted imaging. Muscle Nerve 40, 815\u2013826 (2009).","journal-title":"Muscle Nerve"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/srep02183","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep02183.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep02183.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,6]],"date-time":"2023-01-06T05:35:02Z","timestamp":1672983302000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/srep02183"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,7,15]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2013,12,20]]}},"alternative-id":["BFsrep02183"],"URL":"https:\/\/doi.org\/10.1038\/srep02183","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,7,15]]},"assertion":[{"value":"17 April 2013","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 June 2013","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2013","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"2183"}}